Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study published in the Jan. 29 issue of the New England…
Continue Reading
News Source: medicalxpress.com
Leave a Reply